A Phase I Vaccine Safety and Chemotherapy Dose-Finding Trial of an Allogeneic GM-CSF–Secreting Breast Cancer Vaccine Given in a Specifically Timed Sequence with Immunomodulatory Doses of Cyclophosphamide and Doxorubicin. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland
Autor: | Steven Piantadosi, Janice M. Davis-Sproul, Barbara A. Biedrzycki, John H. Fetting, Reilly Rt, Irena Tartakovsky, Antonio C. Wolff, K Visvanathan, Nancy E. Davidson, Stearns, Elizabeth M. Jaffee, Leisha A. Emens, Deborah K. Armstrong, Beth Onners |
---|---|
Rok vydání: | 2004 |
Předmět: |
Oncology
Chemotherapy medicine.medical_specialty Cyclophosphamide medicine.drug_class business.industry medicine.medical_treatment Genetic enhancement Allogeneic GM-CSF-Secreting Breast Cancer Vaccine Antibiotics medicine.disease Dose finding Breast cancer Internal medicine Immunology Genetics medicine Molecular Medicine Doxorubicin business Molecular Biology medicine.drug |
Zdroj: | Human Gene Therapy. 15:313-337 |
ISSN: | 1557-7422 1043-0342 |
DOI: | 10.1089/104303404322886165 |
Databáze: | OpenAIRE |
Externí odkaz: |